Strategies for Constructing 3D Bioprinted Liver Organ Models

Authors

  • Zhexin Jin School of Medical Devices, Shanghai University of Medicine and Health Sciences, Shanghai, China

DOI:

https://doi.org/10.54097/9c8t1037

Keywords:

3D bioprinting; liver; metabolic partitioning; liver lobules; organ model.

Abstract

Liver diseases are a severe global health challenge. Liver transplantation, as the gold-standard therapy for end stage liver disease, still suffers the fundamental constraint of severe donor shortage. 3D bioprinting technology provides new opportunities to construct functional liver organ model. Metabolic zonation is the core organizational principle of liver function, which is driven by gradients of oxygen and signaling molecules formed during the blood flow from the portal tract to the central vein. The existing in vitro model can not recapitulate this spatial heterogeneity, which severely limits the accuracy of drug metabolism research and toxicity prediction. In this article, the capability boundaries of four mainstream bioprinting technologies, i.e. extrusion-based, DLP photocuring, coaxial printing and embedded sacrificial material printing in reconstructing metabolic zonation are systematically reviewed. On this basis, the multi-technology collaborative strategy is proposed which starts from the target metabolic zonation map and works backward to match the technologies, and the three-layer architecture framework span from microscale topology to macroscale perfusion is constructed. This strategy provides the theoretic reference for advancing 3D bioprinted liver models from morphological biomimicry towards functional biomimicry. The future research may further verify the real efficacy of this framework in reproducing zone-dependent metabolism in in vitro pharmacological screening, and to explore the standardized application pathway in high-throughput system.

Downloads

Download data is not yet available.

References

[1] Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world[J]. Journal of Hepatology, 2019, 70(1): 151-171. DOI: https://doi.org/10.1016/j.jhep.2018.09.014

[2] Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data[J]. Nature Reviews Drug Discovery, 2005, 4(10): 825-833. DOI: https://doi.org/10.1038/nrd1851

[3] Peng W, Unutmaz D, Ozbolat IT. Bioprinting towards physiologically relevant tissue models[J]. Progress in Biomedical Engineering, 2020, 2(3): 032002.

[4] Gebhardt R, Matz-Soja M. Liver zonation: Novel aspects of its regulation and its impact on homeostasis[J]. World Journal of Gastroenterology, 2014, 20(26): 8491-8504. DOI: https://doi.org/10.3748/wjg.v20.i26.8491

[5] Sato A, Kadokura K, Uchida H, et al. An in vitro hepatic zonation model with a continuous oxygen gradient in a microdevice[J]. Biochemical and Biophysical Research Communications, 2014, 453(4): 767-771. DOI: https://doi.org/10.1016/j.bbrc.2014.10.017

[6] Ben-Moshe S, Shapira Y, Moor AE, et al. Spatial sorting enables comprehensive characterization of liver zonation[J]. Nature Metabolism, 2019, 1(9): 899-911. DOI: https://doi.org/10.1038/s42255-019-0109-9

[7] Richert L, Baze A, Parmentier C, et al. Tissue-engineered human hepatocyte systems for predicting the metabolism and toxicity of drugs[J]. Drug Metabolism Reviews, 2006, 38(1): 103-122.

[8] Underhill GH, Khetani SR. Bioengineered liver models for drug testing and cell differentiation studies[J]. Cellular and Molecular Gastroenterology and Hepatology, 2018, 5(3): 245-257. DOI: https://doi.org/10.1016/j.jcmgh.2017.11.012

[9] Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism[J]. Journal of Pharmacology and Experimental Therapeutics, 1973, 187(1): 185-194. DOI: https://doi.org/10.1016/S0022-3565(25)29663-X

[10] Ji S, Golubev G, Guvendiren M. Three-dimensional bioprinting and the quality of bioprinted tissue models[J]. Bioprinting, 2022, 26: e00203.

[11] Kang D, Hong G, An S, et al. Bioprinting of multiscaled hepatic lobules within a highly vascularized construct[J]. Small, 2020, 16(13): e1905505. DOI: https://doi.org/10.1002/smll.201905505

[12] Janani G, Priya S, Dey S, et al. Mimicking native liver lobule microarchitecture in vitro with parenchymal and non-parenchymal cells using 3D bioprinting[J]. ACS Applied Materials & Interfaces, 2022, 14(8): 10167-10186. DOI: https://doi.org/10.1021/acsami.2c00312

[13] Mao Q, Wang Y, Li Y, et al. Fabrication of liver microtissue with liver decellularized extracellular matrix (dECM) bioink by digital light processing (DLP) bioprinting[J]. Materials Science and Engineering C, 2020, 109: 110625. DOI: https://doi.org/10.1016/j.msec.2020.110625

[14] Bhusal A, Dogan E, Nguyen HA, et al. Multi-material digital light processing bioprinting of hydrogel-based microfluidic chips[J]. Biofabrication, 2021, 14(1): 014103. DOI: https://doi.org/10.1088/1758-5090/ac2d78

[15] Taymour R, Kilian D, Ahlfeld T, et al. 3D bioprinting of hepatocytes: core-shell structured co-cultures with fibroblasts for enhanced functionality[J]. Scientific Reports, 2021, 11: 5130. DOI: https://doi.org/10.1038/s41598-021-84384-6

[16] Maji S, Lee M, Lee J, et al. Development of lumen-based perfusable 3D liver in vitro model using single-step bioprinting with composite bioinks[J]. Materials Today Bio, 2023, 21: 100723. DOI: https://doi.org/10.1016/j.mtbio.2023.100723

[17] Lv W, Naren T, Aazmi A, et al. Engineered perfusable hepatic fibrosis model via embedded sacrificial bioprinting recapitulates stiffness-driven fibrogenesis[J]. Advanced Materials, 2026, 38(13): e13401. DOI: https://doi.org/10.1002/adma.202513401

[18] Skylar-Scott MA, Uzel SGM, Nam LL, et al. Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels[J]. Science Advances, 2019, 5(9): eaaw2459. DOI: https://doi.org/10.1126/sciadv.aaw2459

[19] Bhise NS, Ribas J, Manoharan V, et al. A liver-on-a-chip platform with bioprinted hepatic spheroids[J]. Biofabrication, 2016, 8(1): 014101. DOI: https://doi.org/10.1088/1758-5090/8/1/014101

[20] Yang H, Sun L, Lin P, et al. Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure[J]. Gut, 2021, 70: 567-574. DOI: https://doi.org/10.1136/gutjnl-2019-319960

Downloads

Published

15-11-2026

Issue

Section

Articles

How to Cite

Jin, Z. (2026). Strategies for Constructing 3D Bioprinted Liver Organ Models. International Journal of Biology and Life Sciences, 17(2), 52-57. https://doi.org/10.54097/9c8t1037